The Worldcom Public Relations Group, a global partnership of independent public relations firms, conducted research that suggests many large pharmaceutical companies are not taking advantage of online and social media communications. The report, Digital Health Monitor, identifies how 25 global pharma firms manage their online and social media presence globally and in 20 countries.
The report ranks each company in terms of their presence on, and the use of, Apps, Blogs Facebook, Flickr, Instagram, LinkedIn, Pinterest, Tumblr, Twitter and YouTube. It also reviewed the use of these channels by country. Pfizer, for example, came out on top for the use of YouTube, while Novartis ranked as top user for LinkedIn. The report found, however, that none of the companies used these channels to maximum advantage.
Download the full report here.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment
March 14th 2025New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment
March 14th 2025New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.
2 Commerce Drive
Cranbury, NJ 08512